PHAR300 Pharmacotherapy I Exam Prep – Real Practice Questions,
Answers & Detailed Rationales (Updated 2026) | Drug Therapy
Principles, Pharmacokinetics & Pharmacodynamics, Cardiovascular &
Respiratory Pharmacotherapy, Antibiotics & Antimicrobial Medications,
Endocrine & Gastrointestinal Drug Management, Adverse Drug Reactions,
Clinical Case Studies, Medication Safety & Patient Care Planning
Question 1: A 68-year-old male with hypertension, type 2 diabetes, and chronic
kidney disease (eGFR 38 mL/min/1.73m²) presents for medication review. Which
antihypertensive agent is MOST appropriate as first-line therapy to provide both
blood pressure control and renal protection?
A. Hydrochlorothiazide
B. Amlodipine
C. Lisinopril
D. Metoprolol succinate
CORRECT ANSWER: C. Lisinopril
Rationale: ACE inhibitors like lisinopril are first-line for hypertensive patients with
diabetes and CKD because they reduce intraglomerular pressure, decrease proteinuria,
and slow progression of diabetic nephropathy. They provide superior renal protection
compared to other antihypertensives in this population, though monitoring of serum
creatinine and potassium is essential.
Question 2: Which statement BEST describes the mechanism by which sodium-
glucose cotransporter-2 (SGLT2) inhibitors reduce cardiovascular risk in patients
with type 2 diabetes?
A. They directly inhibit cardiac sodium channels to prevent arrhythmias
B. They promote osmotic diuresis, reduce preload, and improve myocardial energetics
C. They block angiotensin II receptors to decrease afterload
D. They enhance insulin secretion from pancreatic beta cells
CORRECT ANSWER: B. They promote osmotic diuresis, reduce preload, and
improve myocardial energetics
Rationale: SGLT2 inhibitors induce glucosuria and natriuresis, leading to osmotic
diuresis that reduces plasma volume and cardiac preload. They also shift myocardial
substrate utilization toward ketones and free fatty acids, improving cardiac efficiency.
These hemodynamic and metabolic effects contribute to the demonstrated reduction in
heart failure hospitalizations and major adverse cardiovascular events.
Question 3: A patient with newly diagnosed atrial fibrillation and a CHA₂DS₂-VASc
score of 3 requires anticoagulation. Which factor is MOST critical when selecting
between warfarin and a direct oral anticoagulant (DOAC)?
A. Patient preference for once-daily dosing
B. Presence of mechanical heart valve
,C. Cost of medication
D. Availability of reversal agent
CORRECT ANSWER: B. Presence of mechanical heart valve
Rationale: DOACs are contraindicated in patients with mechanical heart valves due to
increased risk of thromboembolic and bleeding complications demonstrated in the RE-
ALIGN trial. Warfarin remains the standard of care for anticoagulation in this specific
population. For most other indications, DOACs are preferred due to predictable
pharmacokinetics and fewer drug interactions.
Question 4: Which adverse effect is MOST characteristic of long-term proton pump
inhibitor (PPI) therapy and warrants periodic monitoring?
A. Hyperkalemia
B. Hypomagnesemia
C. Hypercalcemia
D. Hyponatremia
CORRECT ANSWER: B. Hypomagnesemia
Rationale: Chronic PPI use (>1 year) is associated with hypomagnesemia due to
impaired intestinal magnesium absorption. The FDA recommends monitoring
magnesium levels in patients on long-term PPI therapy, especially those taking diuretics
or other medications that lower magnesium. Symptoms include muscle cramps,
arrhythmias, and seizures.
Question 5: A 55-year-old female with rheumatoid arthritis is prescribed
methotrexate. Which supplementation is ESSENTIAL to reduce the risk of
methotrexate-induced toxicity?
A. Vitamin B12
B. Folic acid
C. Iron
D. Calcium
CORRECT ANSWER: B. Folic acid
Rationale: Methotrexate inhibits dihydrofolate reductase, depleting folate stores and
causing mucosal, hematologic, and hepatic toxicity. Daily folic acid supplementation
(1-5 mg) significantly reduces these adverse effects without compromising
methotrexate efficacy. Folinic acid (leucovorin) is reserved for overdose rescue.
Question 6: Which antibiotic is CONTRAINDICATED in a patient with a history of
Clostridioides difficile infection due to high risk of recurrence?
A. Amoxicillin
B. Clindamycin
C. Doxycycline
D. Azithromycin
,CORRECT ANSWER: B. Clindamycin
Rationale: Clindamycin has the highest association with C. difficile infection due to its
broad-spectrum activity against anaerobes and disruption of normal colonic flora. It
should be avoided in patients with prior C. diff unless no alternatives exist. When
necessary, concurrent probiotic therapy and close monitoring are advised.
Question 7: A patient with moderate-severe asthma is prescribed
fluticasone/salmeterol. Which instruction is MOST important to prevent a serious
adverse effect?
A. Take with food to reduce GI upset
B. Rinse mouth with water after inhalation
C. Avoid grapefruit juice
D. Monitor blood glucose daily
CORRECT ANSWER: B. Rinse mouth with water after inhalation
Rationale: Inhaled corticosteroids like fluticasone can cause oropharyngeal
candidiasis and dysphonia due to local immunosuppression. Rinsing the mouth with
water (and spitting) after each use reduces medication residue and significantly lowers
the risk of these local adverse effects without reducing therapeutic efficacy.
Question 8: Which laboratory parameter should be monitored MOST closely in a
patient initiating spironolactone for heart failure?
A. Serum sodium
B. Serum potassium
C. Serum creatinine
D. Liver transaminases
CORRECT ANSWER: B. Serum potassium
Rationale: Spironolactone is a potassium-sparing diuretic that antagonizes
aldosterone, reducing potassium excretion. Hyperkalemia is a serious, potentially life-
threatening adverse effect, especially in patients with renal impairment or those
concurrently taking ACE inhibitors/ARBs. Baseline and periodic potassium monitoring is
mandatory.
Question 9: A patient with bipolar disorder is stabilized on lithium. Which symptom
requires IMMEDIATE evaluation for potential lithium toxicity?
A. Mild hand tremor
B. Increased thirst
C. Coarse tremor with confusion
D. Weight gain
CORRECT ANSWER: C. Coarse tremor with confusion
, Rationale: While fine tremor, polyuria, and weight gain are common chronic side
effects of lithium, coarse tremor accompanied by confusion, ataxia, or slurred speech
suggests acute toxicity (serum level >1.5 mEq/L). This is a medical emergency requiring
immediate lithium discontinuation, hydration, and possibly hemodialysis.
Question 10: Which drug interaction poses the GREATEST risk when combining
simvastatin with clarithromycin?
A. Reduced antibiotic efficacy
B. Increased risk of rhabdomyolysis
C. QT interval prolongation
D. Hypoglycemia
CORRECT ANSWER: B. Increased risk of rhabdomyolysis
Rationale: Clarithromycin is a strong CYP3A4 inhibitor that significantly increases
simvastatin plasma concentrations by reducing its metabolism. This dramatically
elevates the risk of statin-induced myopathy and rhabdomyolysis. Simvastatin dose
should be limited to 10 mg/day with clarithromycin, or an alternative statin (e.g.,
pravastatin) or antibiotic should be selected.
Question 11: A 72-year-old male with benign prostatic hyperplasia (BPH) and
hypertension is prescribed tamsulosin. Which adverse effect should the
pharmacist specifically counsel about?
A. Dry cough
B. Orthostatic hypotension
C. Hyperkalemia
D. Photosensitivity
CORRECT ANSWER: B. Orthostatic hypotension
Rationale: Tamsulosin is an alpha-1a selective adrenergic antagonist that relaxes
prostatic smooth muscle. Although uroselective, it can still cause vasodilation and
orthostatic hypotension, especially with the first dose or dose increases. Patients
should be advised to rise slowly from sitting/lying positions and to avoid driving until
effects are known.
Question 12: Which medication is FIRST-LINE for acute gout flare management in a
patient with normal renal function and no contraindications?
A. Allopurinol
B. Colchicine
C. Febuxostat
D. Probenecid
CORRECT ANSWER: B. Colchicine
Rationale: Colchicine, NSAIDs, or corticosteroids are first-line for acute gout flares.
Colchicine is particularly effective when initiated within 36 hours of symptom onset.
Answers & Detailed Rationales (Updated 2026) | Drug Therapy
Principles, Pharmacokinetics & Pharmacodynamics, Cardiovascular &
Respiratory Pharmacotherapy, Antibiotics & Antimicrobial Medications,
Endocrine & Gastrointestinal Drug Management, Adverse Drug Reactions,
Clinical Case Studies, Medication Safety & Patient Care Planning
Question 1: A 68-year-old male with hypertension, type 2 diabetes, and chronic
kidney disease (eGFR 38 mL/min/1.73m²) presents for medication review. Which
antihypertensive agent is MOST appropriate as first-line therapy to provide both
blood pressure control and renal protection?
A. Hydrochlorothiazide
B. Amlodipine
C. Lisinopril
D. Metoprolol succinate
CORRECT ANSWER: C. Lisinopril
Rationale: ACE inhibitors like lisinopril are first-line for hypertensive patients with
diabetes and CKD because they reduce intraglomerular pressure, decrease proteinuria,
and slow progression of diabetic nephropathy. They provide superior renal protection
compared to other antihypertensives in this population, though monitoring of serum
creatinine and potassium is essential.
Question 2: Which statement BEST describes the mechanism by which sodium-
glucose cotransporter-2 (SGLT2) inhibitors reduce cardiovascular risk in patients
with type 2 diabetes?
A. They directly inhibit cardiac sodium channels to prevent arrhythmias
B. They promote osmotic diuresis, reduce preload, and improve myocardial energetics
C. They block angiotensin II receptors to decrease afterload
D. They enhance insulin secretion from pancreatic beta cells
CORRECT ANSWER: B. They promote osmotic diuresis, reduce preload, and
improve myocardial energetics
Rationale: SGLT2 inhibitors induce glucosuria and natriuresis, leading to osmotic
diuresis that reduces plasma volume and cardiac preload. They also shift myocardial
substrate utilization toward ketones and free fatty acids, improving cardiac efficiency.
These hemodynamic and metabolic effects contribute to the demonstrated reduction in
heart failure hospitalizations and major adverse cardiovascular events.
Question 3: A patient with newly diagnosed atrial fibrillation and a CHA₂DS₂-VASc
score of 3 requires anticoagulation. Which factor is MOST critical when selecting
between warfarin and a direct oral anticoagulant (DOAC)?
A. Patient preference for once-daily dosing
B. Presence of mechanical heart valve
,C. Cost of medication
D. Availability of reversal agent
CORRECT ANSWER: B. Presence of mechanical heart valve
Rationale: DOACs are contraindicated in patients with mechanical heart valves due to
increased risk of thromboembolic and bleeding complications demonstrated in the RE-
ALIGN trial. Warfarin remains the standard of care for anticoagulation in this specific
population. For most other indications, DOACs are preferred due to predictable
pharmacokinetics and fewer drug interactions.
Question 4: Which adverse effect is MOST characteristic of long-term proton pump
inhibitor (PPI) therapy and warrants periodic monitoring?
A. Hyperkalemia
B. Hypomagnesemia
C. Hypercalcemia
D. Hyponatremia
CORRECT ANSWER: B. Hypomagnesemia
Rationale: Chronic PPI use (>1 year) is associated with hypomagnesemia due to
impaired intestinal magnesium absorption. The FDA recommends monitoring
magnesium levels in patients on long-term PPI therapy, especially those taking diuretics
or other medications that lower magnesium. Symptoms include muscle cramps,
arrhythmias, and seizures.
Question 5: A 55-year-old female with rheumatoid arthritis is prescribed
methotrexate. Which supplementation is ESSENTIAL to reduce the risk of
methotrexate-induced toxicity?
A. Vitamin B12
B. Folic acid
C. Iron
D. Calcium
CORRECT ANSWER: B. Folic acid
Rationale: Methotrexate inhibits dihydrofolate reductase, depleting folate stores and
causing mucosal, hematologic, and hepatic toxicity. Daily folic acid supplementation
(1-5 mg) significantly reduces these adverse effects without compromising
methotrexate efficacy. Folinic acid (leucovorin) is reserved for overdose rescue.
Question 6: Which antibiotic is CONTRAINDICATED in a patient with a history of
Clostridioides difficile infection due to high risk of recurrence?
A. Amoxicillin
B. Clindamycin
C. Doxycycline
D. Azithromycin
,CORRECT ANSWER: B. Clindamycin
Rationale: Clindamycin has the highest association with C. difficile infection due to its
broad-spectrum activity against anaerobes and disruption of normal colonic flora. It
should be avoided in patients with prior C. diff unless no alternatives exist. When
necessary, concurrent probiotic therapy and close monitoring are advised.
Question 7: A patient with moderate-severe asthma is prescribed
fluticasone/salmeterol. Which instruction is MOST important to prevent a serious
adverse effect?
A. Take with food to reduce GI upset
B. Rinse mouth with water after inhalation
C. Avoid grapefruit juice
D. Monitor blood glucose daily
CORRECT ANSWER: B. Rinse mouth with water after inhalation
Rationale: Inhaled corticosteroids like fluticasone can cause oropharyngeal
candidiasis and dysphonia due to local immunosuppression. Rinsing the mouth with
water (and spitting) after each use reduces medication residue and significantly lowers
the risk of these local adverse effects without reducing therapeutic efficacy.
Question 8: Which laboratory parameter should be monitored MOST closely in a
patient initiating spironolactone for heart failure?
A. Serum sodium
B. Serum potassium
C. Serum creatinine
D. Liver transaminases
CORRECT ANSWER: B. Serum potassium
Rationale: Spironolactone is a potassium-sparing diuretic that antagonizes
aldosterone, reducing potassium excretion. Hyperkalemia is a serious, potentially life-
threatening adverse effect, especially in patients with renal impairment or those
concurrently taking ACE inhibitors/ARBs. Baseline and periodic potassium monitoring is
mandatory.
Question 9: A patient with bipolar disorder is stabilized on lithium. Which symptom
requires IMMEDIATE evaluation for potential lithium toxicity?
A. Mild hand tremor
B. Increased thirst
C. Coarse tremor with confusion
D. Weight gain
CORRECT ANSWER: C. Coarse tremor with confusion
, Rationale: While fine tremor, polyuria, and weight gain are common chronic side
effects of lithium, coarse tremor accompanied by confusion, ataxia, or slurred speech
suggests acute toxicity (serum level >1.5 mEq/L). This is a medical emergency requiring
immediate lithium discontinuation, hydration, and possibly hemodialysis.
Question 10: Which drug interaction poses the GREATEST risk when combining
simvastatin with clarithromycin?
A. Reduced antibiotic efficacy
B. Increased risk of rhabdomyolysis
C. QT interval prolongation
D. Hypoglycemia
CORRECT ANSWER: B. Increased risk of rhabdomyolysis
Rationale: Clarithromycin is a strong CYP3A4 inhibitor that significantly increases
simvastatin plasma concentrations by reducing its metabolism. This dramatically
elevates the risk of statin-induced myopathy and rhabdomyolysis. Simvastatin dose
should be limited to 10 mg/day with clarithromycin, or an alternative statin (e.g.,
pravastatin) or antibiotic should be selected.
Question 11: A 72-year-old male with benign prostatic hyperplasia (BPH) and
hypertension is prescribed tamsulosin. Which adverse effect should the
pharmacist specifically counsel about?
A. Dry cough
B. Orthostatic hypotension
C. Hyperkalemia
D. Photosensitivity
CORRECT ANSWER: B. Orthostatic hypotension
Rationale: Tamsulosin is an alpha-1a selective adrenergic antagonist that relaxes
prostatic smooth muscle. Although uroselective, it can still cause vasodilation and
orthostatic hypotension, especially with the first dose or dose increases. Patients
should be advised to rise slowly from sitting/lying positions and to avoid driving until
effects are known.
Question 12: Which medication is FIRST-LINE for acute gout flare management in a
patient with normal renal function and no contraindications?
A. Allopurinol
B. Colchicine
C. Febuxostat
D. Probenecid
CORRECT ANSWER: B. Colchicine
Rationale: Colchicine, NSAIDs, or corticosteroids are first-line for acute gout flares.
Colchicine is particularly effective when initiated within 36 hours of symptom onset.
